Suciu, I.M.; Luca, S.A.; Crișan, S.; Cozlac, A.-R.; Stoica, S.; Luca, C.T.; Timar, B.; Gaita, D.
Do SGLT2 Inhibitors Improve Cardiovascular Outcomes After Acute Coronary Syndrome Regardless of Diabetes? A Systematic Review and Meta-Analysis. Medicina 2025, 61, 1866.
https://doi.org/10.3390/medicina61101866
AMA Style
Suciu IM, Luca SA, Crișan S, Cozlac A-R, Stoica S, Luca CT, Timar B, Gaita D.
Do SGLT2 Inhibitors Improve Cardiovascular Outcomes After Acute Coronary Syndrome Regardless of Diabetes? A Systematic Review and Meta-Analysis. Medicina. 2025; 61(10):1866.
https://doi.org/10.3390/medicina61101866
Chicago/Turabian Style
Suciu, Ioana Maria, Silvia Ana Luca, Simina Crișan, Alina-Ramona Cozlac, Svetlana Stoica, Constantin Tudor Luca, Bogdan Timar, and Dan Gaita.
2025. "Do SGLT2 Inhibitors Improve Cardiovascular Outcomes After Acute Coronary Syndrome Regardless of Diabetes? A Systematic Review and Meta-Analysis" Medicina 61, no. 10: 1866.
https://doi.org/10.3390/medicina61101866
APA Style
Suciu, I. M., Luca, S. A., Crișan, S., Cozlac, A.-R., Stoica, S., Luca, C. T., Timar, B., & Gaita, D.
(2025). Do SGLT2 Inhibitors Improve Cardiovascular Outcomes After Acute Coronary Syndrome Regardless of Diabetes? A Systematic Review and Meta-Analysis. Medicina, 61(10), 1866.
https://doi.org/10.3390/medicina61101866